|The goal of this clinical research study is to learn more about the |
characteristics of CLL, including genes and chromosome abnormalities and
proteins expressed by the leukemia cells, which may help doctors predict if
patients who receive standard treatment (fludarabine, cyclophosphamide, and
rituximab) for the first time will experience a complete remission.